Historic Addiction Treatment Facility Brighton Hospital Becomes Hythiam's First Combined Inpatient and Outpatient Licensee in Michigan; Hospital Based on 12-Step Philosophy Looks Forward to Enhancing Care With PROMETA(R) Protocols
Posted on: Thursday, 21 September 2006, 09:06 CDT
Hythiam, Inc. (NASDAQ:HYTM), a healthcare services management company that licenses the PROMETA(R) treatment protocols designed to treat alcohol, methamphetamine and cocaine dependence, announced today that the PROMETA protocols have been licensed for use at St. John Health's Brighton Hospital, a historic facility founded by Harry Henderson, a colleague of Dr. Bill Wilson, the co-founder of Alcoholics Anonymous, and solely dedicated to the treatment of addictive disorders. Located in Brighton, Michigan, Brighton Hospital is one of nine hospitals and 125 medical facilities that are a part of St. John Health, a major provider of healthcare in southeastern Michigan. Both inpatient and outpatient treatment models are employed at Brighton Hospital, which is staffed by addiction medicine physicians and addiction-credentialed clinicians.
"We embrace a comprehensive treatment philosophy at Brighton Hospital for the successful recovery of all our patients," said Denise Bertin-Epp, President of Brighton Hospital. "The PROMETA protocols combine the latest advances in medical and psychosocial therapies with which we hope to provide our patients a solid foundation for lasting recovery. This approach fits perfectly with our commitment to the proven 12-step model. We look forward to sharing results achieved with PROMETA among the network of health practitioners in the St. John Health system."
"We are pleased to partner with Brighton Hospital, a facility with extensive experience and knowledge of the best ways to successfully treat addiction," said Hythiam's Chairman and CEO, Terren Peizer. "The PROMETA protocols have passed Brighton Hospital's rigorous review of new substance dependence treatments, and can serve as a complement to their existing treatment models."
About Brighton Hospital and St. John Health
Brighton Hospital was founded more than 50 years ago on visionary Harry Henderson's belief that alcoholism is a treatable disease. When Mr. Henderson opened this home style treatment center in a serene setting, he set a high standard for treatment on which many other treatment centers modeled themselves.
Brighton continues to be a standard bearer and innovator in chemical dependency treatment based on the medical model and 12-step program participation. The staff at Brighton Hospital knows that addiction to any drug can be treated when people find help and hope. People with a chemical dependency and their families find both at Brighton - a fully licensed and accredited acute care hospital.
One of Mr. Henderson's colleagues was Dr. Bill Wilson, a co-founder of Alcoholics Anonymous. They believed that alcoholism is a physical, mental and spiritual disease that can be treated with medical intervention, counseling and a strong spiritual life supported by 12-step programs.
St. John Health is comprised of nine hospitals, plus more than 125 medical facilities in southeast Michigan. Its history of serving the Detroit area dates back to 1844. Every year at St. John Health, thousands of patients in southeast Michigan receive exceptional care through dozens of services, in and out of the hospital setting. Services include heart, cancer, physical rehabilitation, behavioral medicine, surgery, emergency and urgent care.
About PROMETA(R)
Hythiam's PROMETA(R) treatment protocols are designed for use by healthcare providers seeking to treat individuals diagnosed with dependencies to alcohol, cocaine or methamphetamine, as well as combinations of these drugs. The PROMETA treatment protocols comprise nutritional supplements, FDA-approved oral and IV medications used off-label and separately administered in a unique dosing algorithm, as well as psychosocial or other recovery-oriented therapy chosen by the patient and his or her treatment provider. As a result, PROMETA represents an innovative approach to managing alcohol, cocaine, or methamphetamine dependence that is designed to address physiological, nutritional, and psychosocial aspects of the disease, and is thereby intended to offer patients an opportunity to achieve sustained recovery. To learn more, please visit www.prometainfo.com.
About Hythiam, Inc.
Hythiam(R) is a healthcare services management company focused on delivering solutions for those suffering from alcoholism and other substance dependencies. Hythiam researches, develops, licenses and commercializes innovative physiological, nutritional, and behavioral treatment protocols that seek to address substance dependence. Additionally, Hythiam provides proprietary administrative services to assist physicians and facilities with staff education, training, marketing and outreach support, and outcomes tracking for data analysis. For further information, please click on www.hythiam.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history and lack of statistically significant formal research studies, the risk that treatment protocols might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the healthcare industry, and additional risks factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at http://www.sec.gov.
Source: Business Wire
Related Articles
- CEL-SCI Announces Start of First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
- CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
- InPlace Medical Solutions Announces Advanced Medical Services for Offshore and Remote Locations
- Assurant Health Partners With TelaDoc Medical Services
- Health Net Federal Services Hires Medical Director
- Louis W. Sullivan, M.D., Former Secretary of the U.S. Department of Health and Human Services, Joins Consumer Health Services, Inc.'s National Medical Advisory Board
- Blue Cross Blue Shield Member Plan to Evaluate Hythiam's PROMETA Protocols
- Acute and Immediate Impact of Hythiam's PROMETA(R) Protocols on Cravings and Cognition to Be Evaluated in Additional Double-Blind Placebo-Controlled Studies
- Hospital Takes First Steps Toward Building New Medical-Services Building
User Comments (0)

RSS Feeds